RT @FanLingXi: 柳叶刀文章,我们的疫苗! 🇨🇳🇨🇳🇨🇳 全人类的公共疫苗! 期待更多好消息!
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @OACerebro: El primer ensayo de la #vacuna contra #COVIDー19: ▪️es segura ▪️induce una respuesta inmune rápida #BuenasNoticias First…
RT @ecapobianco: Some good news, to be taken with maximum caution, but still good news... #COVIDー19 @ifrc https://t.co/ghlQhKFYUE
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @ecapobianco: Some good news, to be taken with maximum caution, but still good news... #COVIDー19 @ifrc
RT @ecapobianco: Some good news, to be taken with maximum caution, but still good news... #COVIDー19 @ifrc https://t.co/ghlQhKFYUE
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @ecapobianco: Some good news, to be taken with maximum caution, but still good news... #COVIDー19 @ifrc https://t.co/ghlQhKFYUE
RT @MoNscience: .@TheLancet is dropping dimes this morning! First the hydroxychloroquine study... NOW: First human trial of COVID-19 vacci…
RT @ecapobianco: Some good news, to be taken with maximum caution, but still good news... #COVIDー19 @ifrc
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @PleuralPOCUS: Primer ensayo en humanos de la #vacuna #COVID19 encuentra que es seguro e induce una respuesta inmune rápida. El ensayo…
El primer ensayo de la #vacuna contra #COVIDー19: ▪️es segura ▪️induce una respuesta inmune rápida #BuenasNoticias First human trial of #COVID19 #vaccine finds: ▪️it is safe ▪️induces rapid #immune response 👉 https://t.co/WXxBEaCi4d https://t.co/SwUq
RT @ecapobianco: Some good news, to be taken with maximum caution, but still good news... #COVIDー19 @ifrc https://t.co/ghlQhKFYUE
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @FanLingXi: 柳叶刀文章,我们的疫苗! 🇨🇳🇨🇳🇨🇳 全人类的公共疫苗! 期待更多好消息!
RT @CarlosdelRio7: Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation…
Il primo studio sull'uomo di un vaccino #COVIDー19 ha mostrato che è sicuro, ben tollerato e induce una risposta immunitaria rapida. "Questi risultati rappresentano un'importante pietra miliare". https://t.co/eyTPdLb5hN
RT @MoNscience: .@TheLancet is dropping dimes this morning! First the hydroxychloroquine study... NOW: First human trial of COVID-19 vacci…
Massive.
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @4xInsight: More good news about Vaccines https://t.co/28PCkpXZzt
Awesome!
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @MoNscience: .@TheLancet is dropping dimes this morning! First the hydroxychloroquine study... NOW: First human trial of COVID-19 vacci…
Primer paso completado. A esperar el fase 2. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial - The Lancet https://t.co/8yzE5yt2Yi
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
More good news about Vaccines
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
Some good news, to be taken with maximum caution, but still good news... #COVIDー19 @ifrc
RT @MoNscience: .@TheLancet is dropping dimes this morning! First the hydroxychloroquine study... NOW: First human trial of COVID-19 vacci…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @MoNscience: .@TheLancet is dropping dimes this morning! First the hydroxychloroquine study... NOW: First human trial of COVID-19 vacci…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored #COVID19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial - The Lancet https://t.co/pjxWHfKH7X
RT @Xi_Fan: This study about Covid19 vaccine is researched by China. This success research of vaccine belongs to all mankind. Wish more goo…
The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans. https://t.co/Ut0cSPZYBo
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @MoNscience: .@TheLancet is dropping dimes this morning! First the hydroxychloroquine study... NOW: First human trial of COVID-19 vacci…
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial https://t.co/9EabPyllht
RT @MeganMolteni: China's CanSino is out today with Phase 1 data on its Covid-19 vaccine candidate. Emphasis on data. In a journal. Not a t…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @CarlosdelRio7: Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation…
👏👏👏
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @CarlosdelRio7: Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
Chine : L'essai sur le vaccin COVID19, le 1er vaccin de ce type à atteindre un essai clinique de phase 1, s'est révélé sûr, bien toléré et capable de générer une réponse immunitaire contre le SRAS-COV-2 chez l'homme, selon une étude publiée par The Lancet.
Good news!
RT @CarlosdelRio7: Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation…
RT @MoNscience: .@TheLancet is dropping dimes this morning! First the hydroxychloroquine study... NOW: First human trial of COVID-19 vacci…
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial https://t.co/Y31rFS5El3
RT @CarlosdelRio7: Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @docramiro: Recién publicado, estudio fase 1 de la #vacuna vectorizada Ad5 para #COVID19 en humanos (195 participantes). Sin efectos adv…
Le premier essai humain d'un vaccin COVID-19 a montré qu'il est sûr, bien toléré et induit une réponse immunitaire rapide. «Ces résultats représentent une étape importante.» #Covid_19 #COVIDー19 https://t.co/eyTPdLb5hN
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial https://t.co/k1PvUJzVby. An Ad5 vectored #COVID19 vaccine was safe and immunogenic.
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
good !
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
@CherryL10955185 帮你贴上柳叶刀推文https://t.co/yuy6IlFQQ4
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @Xi_Fan: This study about Covid19 vaccine is researched by China. This success research of vaccine belongs to all mankind. Wish more goo…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
RT @TheLancet: NEW Research—First human trial of #COVID19 vaccine finds it is safe and induces rapid immune response: finding from a dose-e…
コロナワクチン フェイズ1治験の報告、第一報。効いてそうな感じだが、治療効果の判定はこれではできない。後期フェイズの結果が待たれる。